Clearstead Trust’s CME Group CME Stock Holding History

Clearstead Trust’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$729K	Sell	3,300 -227	-6%	-$62.8K	0.1%	90
2026 Q1	$1.04M	Hold	3,527	–	–	0.17%	72
2025 Q4	$963K	Buy	3,527 +241	+7%	+$65.5K	0.15%	77
2025 Q3	$888K	Hold	3,286	–	–	0.15%	80
2025 Q2	$906K	Buy	3,286 +163	+5%	+$44.3K	0.17%	76
2025 Q1	$829K	Buy	3,123 +57	+2%	+$14.1K	0.18%	75
2024 Q4	$712K	Hold	3,066	–	–	0.15%	77
2024 Q3	$677K	Hold	3,066	–	–	0.16%	71
2024 Q2	$603K	Buy	3,066 +652	+27%	+$135K	0.15%	70
2024 Q1	$520K	Hold	2,414	–	–	0.14%	80
2023 Q4	$508K	Buy	+2,414	New	+$515K	0.14%	92
2023 Q1	–	Sell	-19	Closed	-$3K	–	377
2022 Q4	$3K	Hold	19	–	–	﹤0.01%	349
2022 Q3	$3K	Buy	+19	New	+$3.75K	﹤0.01%	336

Other funds holding CME

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Clearstead Trust's CME Position: Q2 2026 in Review

Clearstead Trust reduced its CME Group (CME) stake by 6.4% in Q2 2026, selling an estimated $62.8K and leaving 3,300 shares worth $729K. The position accounts for 0.1% of the portfolio, ranked #90.

Clearstead Trust first reported a position in CME in Q3 2022 and has held it in 13 quarters since. The position peaked at $1.04M in Q1 2026. 1,698 funds tracked by Wall St. Rank hold CME as of Q2 2026.

Clearstead Trust held 3,300 shares of CME Group worth $729K as of Q2 2026.
Clearstead Trust sold 227 CME Group shares in Q2 2026, an estimated $62.8K.
CME Group made up 0.1% of Clearstead Trust's portfolio in Q2 2026, its #90 holding.
Clearstead Trust first reported a position in CME Group in Q3 2022 and has held it in 13 quarters since.
Clearstead Trust's CME Group position peaked at $1.04M in Q1 2026.
1,698 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Clearstead Trust's 13F filing for Q2 2026, filed 6 Aug 2026.